VYNE: VYNE Therapeutics Inc. Stock

by  •  • Comments Off on VYNE: VYNE Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 26.77
Enterprise Value ($M) 6.84
Book Value ($M) 52.09
Book Value / Share 3.51
Price / Book 0.51
NCAV ($M) 49.62
NCAV / Share 3.35
Price / NCAV 0.54

Profitability (mra)
Return on Invested Capital (ROIC) -0.76
Return on Assets (ROA) -0.43
Return on Equity (ROE) -0.48

Liquidity (mrq)
Quick Ratio 4.35
Current Ratio 4.35

Balance Sheet (mrq) ($M)
Current Assets 64.44
Assets 66.91
Liabilities 14.82
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.50
Operating Income -43.64
Net Income -39.83
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -33.97
Cash from Investing 23.36
Cash from Financing -0.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Soleus Capital Master Fund, L.P. 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 4,942 78,958 6.26
2025-04-16 3,152 112,409 2.80
2025-04-15 12,562 140,666 8.93
2025-04-14 32,360 173,420 18.66

(click for more detail)

Similar Companies
VTGN – Vistagen Therapeutics, Inc. VTVT – vTv Therapeutics Inc.
VXRT – Vaxart, Inc. WHWK – Whitehawk Therapeutics, Inc.
WINT – Windtree Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io